Join TEP for Refinement of the Nursing Home Antipsychotic Medication Measures
Submit Nominations by November 29, 5 p.m. ET
Acumen, LLC supports CMS in the maintenance and development of quality measures for use in the IRF, LTCH, SNF, and HH Quality Reporting Programs (QRPs) and the Nursing Home Quality Initiative (NHQI). These measures fall into several domains including hospitalizations, patient safety, healthcare-associated infections, and function, to name a few, and are designed to improve care quality and to enable Medicare beneficiaries to make informed choices when selecting a healthcare provider. Among these measures are the measures of how nursing homes use antipsychotic drugs. The Office of Inspector General (OIG) released a report showing that CMS’s use of the Minimum Data Set (MDS) as its sole data source to assess the number of residents receiving antipsychotic medications may not accurately reflect antipsychotic prescribing in NH facilities. OIG recommended CMS to consider using additional data sources to ensure the accuracy of what is being reported on the MDS.
To ensure existing and newly developed measures meet CMS program requirements and goals while maintaining high levels of scientific acceptability, Acumen is convening a TEP. Acumen will organize a panel of stakeholders from a broad base of expertise (e.g., clinical, policy and program, measure development, technical, etc.) and solicit their input regarding MDS reporting of data elements used by the NH antipsychotic measures and explore refinement options. This input will be used to inform the refinement and development of the antipsychotic medication measures.
The Technical Expert Panel nomination period is now extended and will close on November 29th, 2022 at 5PM EST. Please submit all nomination materials by the closing date.
If you wish to nominate yourself or other individuals for consideration, please visit the web posting on the CMS Technical Expert Panels: Currently Accepting Nominations page for more information.